Increasing the secretion of reactive oxygen intermediates (ROI) by monocytes in the synovial fluid is an indicator to determine the severity of joint inflammation. Previous studies have shown that curcumin inhibit the osteoarthritis progression with its ability to inhibite the activity of the nitric oxide synthase (NOS) enzyme from macrophages. In this prospective randomized open end blinded evaluations = PROBE study, 80 patients with knee osteoarthritis were eligable. The subject were devided in to two group: group who received 3 x 30 mg of curcuminoid from Curcuma domestica Val. extract (curcuminoid group) and group who received 3 x 25 mg of diclofenac sodium (diclofenac group) as comparison. The treatment was for 4 weeks time. The secretion of ROI by sinovial fluid monocytes was calculated by scoring the amount of formazan formation after neutral red staining in nitrobleu tetrazolium reduction assay. The result of this study showed that the secretion of ROI by synovial fluid monocytes was significantly decreased in both groups (p <0.001) respectively. There was no significant difference in decreasing of ROI secretion of synovial fluid monocytes between both treatment groups (p = 0.92).
Introduction
Osteoarthritis (OA) is the most often joint disease found in people. The disease is a major cause of musculoskeletal disorders throughout the world and become the sec largest cause of physical disability after ischemic heart disease for over 50 years of age. This disease causes loss of working h and high cost of treatment (Dieppe, 2008) . The prevalence of OA increases with increasing of age (Breedveld, 2004) .
Pathophysiology of OA is mixed between the process of degeneration and inflammation, it is evidenced by the degeneration of cartilage which is accompanied by an increase in leukocyte count and pro-inflammatory cytokines in synovial fluid of affected joints (Ratiner et al., 2001) . In OA there is imbalance between synthesis and degradation of joint cartilage, and subchondral bone. Joint degradation is initiated by mechanical loading which resulting in chondrocyte metabolism disorders, production of proteolytic enzymes such as matrix metalloproteinase (MMP) and damage of joint cartilage. The occurrence of multiple microfractur cause degradation and depletion of vulnerable joints, changes in joint architecture and the formation of osteophyte.
If it happen, the osteoarthritis progression will continue. Changes in architecture of the joint resulting in joint mechanics change that cause increase pressure on the joints, further joint damage, release of damage enzymes and inflammation of the joints (Berenbaum, 2008) . In the elimination process of foreign antigens or when interacting with stimuli such as cytokines, the oxidative burst of monocytes showed an increased capacity to produce ROI in large quantities. Reactive oxygen intermediates play an important role in the process of inflammation and tissue damage (Felson, 2008) The study of anti-inflammatory activity of curcumin has been done. Curcumin one component of curcuminoid has more powerful anti-inflammatory activity than the other components (Parslow & Bainton, 2003) . In vitro curcumin inhibite the activity of phospholypase, lypoxigenase, cycloxigenase-2 (COX-2), leucotrien, prostaglandin, thromboxane, Nitric Oxide, collagenase, elastase, hyaluronidase, interferon, TNF-α and IL-12. In people with rheumatoid arthritis, curcumin reduces the stiffness, swollen joints and walking time. Curcumin also suppressed the postoperative inflammation (Joe et al., 2004) . Secretion of ROI by monocytes in the synovial fluid determine the severity of joint inflammation. Two important mediators produced by monocytes in the synovial fluid in initiate the inflammatory process and elimination of antigen are COX-2 enzyme and reactive oxygen intermediates (ROI). Increasing of ROI secretion by monocytes in the synovial fluid will follow by increasing of joint inflammation (Chainani, 2003) . Production of nitric oxide and oxygen radicals in chondrocytes are affected by the biological process of osteoarthritis and rheumatoid arthritis (Mazzetti et al., 2001 ). The results of previous studies have shown that curcumin inhibits the osteoarthritis process (Ukil et al., 2003) .
This study aim to assess the ability of curcuminoid from Curcuma domestica Val. rhyzome extract in inhibit the ROI secretion of synovial fluid monocytes in osteoarthritis.
Materials and Methods

Research design
This is a prospective randomized open end blinded evaluation (PROBE) study.
Materials
Extraction was done by sorted the Curcuma domestica Val. rhyzome then washed, cut into pieces with a thickness of 1-2 mm and dried with drying cupboard for 24 h at 40 0 C to obtain maximum water content of 10% v/w. After dry it was made to be some powder. The powder was mixed with ethanol and then macerated (soaked) for 24 h, then filtered with a Buchner funnel (with vacuum pressure). Collected filtrate was evaporated at 45 0 C in vacuum condition. For the determination of curcuminoids curcumin standard solution used with varying degrees of concentration. Extract obtained was diluted to 100 mg/mL and touched on silica gel GF 254 plates and then eluted with a mobile phase system chloroform-methanol (97-3) v/w. Detection of spots is done by ultraviolet light 254 nm and 365 nm. The scan was then performed by Thin Layer Chromatography scanner. The level of curcumin, desmetoxi curcumin and bisdesmetoxi curcumin as components of curcuminoids was calculated by linear regression method. The extract was entered in the capsuls which the dose of 30 mg curcuminoid. The other capsules contain 25 mg of sodium diclofenac.
Research subjects
This study was run at the Rheumatology Clinic, Department of Internal Medicine Faculty of Medicine, Universitas Gadjah Mada/Dr. Sardjito Hospital -Yogyakarta. The study population were patients with knee OA, registered and were still controlled in Dr. Sardjito General Hospital. Random selection was done among 168 patients to find 80 patients who eligible in this research. The subjects have no arthritis other than osteoarthritis, had no abnormalities of liver, kidney or bone marrow function, did not have any history of gastritis, peptic or duodenal ulcer, no history of hypersensitivity to diclofenac sodium and curcuminoid, did not use anti-coagulant medication or other anti-inflammatory drugs, and agree to follow the study with signed the informed consent.
After 1 week washed-out, the random assignment was done so that the sample was divided into treatment groups and control groups. The treatment was for 4 weeks period. The treatment group were given 3 x 30 mg curcuminoid from Curcuma Val. rhyzome extract, while the control group were given 3 x 25 mg diclofenac sodium. Assessment of the treatment results was performed before and after 4 weeks treatment by scoring the formazan sedimentation in the cytoplasm of monocytes. Data analysis was conducted on the amount of ROI secretion by synovial fluid monocytes before and after treatment.
Laboratory examination
Before starting the treatment, 2 mL of synovial fluid was taken from the affected knee. The culture of monocytes by PMA stimulation was performed. By nitroblue tetrazolium (NBT) reduction assay, the formazan sedimentation was able to assess. Since the formazan is the end result of the reaction between the NBT and ROI, the amount of ROI secretion by synovial fluid monocytes were calculated by scoring the formazan sedimentation in the cytoplasm of monocytes. Monocytes culture was added by 500 ul NBT solution containing 125 ng/mL PMA and incubated at 37 o C and 5% CO 2 for 60 min. Cells was then washed 3 times with PBS, dried at room temperature and fixed in absolute methanol for 30 sec and painted with neutral red solution for 15 min and then washed with distilled water then dried at room temperature and ready to be observed. The cytoplasm of monocytes without secreted ROI was pale, while that secreted ROI looks blue insoluble formazan sedimentation as a result of ROI and NBT reaction. Based on the amount of formazan sedimentation the monocytes were differentiated into 4 groups. Without secreted ROI (no formazan deposits in the cytoplasm, given the value 0), which secreted a little amount of ROI (maximum formazan sedimentation reaches a quarter of the cytoplasm, given the value 1), which secreted ROI in large quantities (formazan sedimentation between a quarter to three-quarter of the cytoplasm, given the value 2) and which secreted ROI in a very large quantities (more than three-quarter formazan sedimentation of the cytoplasm, given the value 3) (Figure 1 ). Before the study started, firstly the researchers test the value of kappa to determine intraobserver and interobserver consistency of the ROI value secreted by monocytes in the synovial fluid. Observation was done by two assessor. Each assessor observed 40 monocytes then calculated the value of intraobserver and interobserver consistency. In assessing the effectiveness of the treatments each assessor observed 100 monocytes in each preparate before starting the treatmen and after 4 weeks treatment.
Statistical analysis
Unpaired Student's -t test was performed for analysis.
Results and Discussions
A total of 80 patients with knee osteoarthritis were eligible and willing to participate in this study. Subjects were divided randomly into two groups: the treatment group (named curcuminoid group) were given 3 x 30 mg curcuminoid from Curcuma domestica Val. rhyzome extract, while the control group (named diclofenac group) were given 3 x 25 mg diclofenac sodium.
In curcuminoid group number of subjects who participated in the study were 39 patients consisting of 15 men and 24 women. The mean age was 64.05 ± 8.83 years. The duration suffering of osteoarthritis was 41.23 ± 32.60 months. The body mass index was 26.28 ± 3.62 kg / m 2. Five subjects were excluded from the study with the reasons: 1 Subject drank piroxicam, 1 subject experienced ureter colic due to urinary tract stones, 1 subject had hematuria due to tumor of vesica urinaria, 1 subject stopped the curcuminoid treatment as his family request and 1 subject experienced an acute exacerbation of chronic obstructive pulmonary disease. Number of subjects in the curcuminoid group who finished the study was 34 patients, comprising 11 men and 23 women.
In diclofenac group the number of subjects who participated in the study were 41 patients consisting of 12 men and 29 women. The mean age was 64.56 ± 8.86 years. The duration suffering of osteoarthritis was 40.37 ± 30.87 months. The body mass index was 26.44 ± 4.79 kg / m 2. Two subjects were excluded from the study with the reasons: 1 subject experiencing dyspepsia on the seventh day of treatment which did not improve by giving omeprazole 10 mg 1 tablet daily and 1 subject has no synovial fluid in aspiration.
Number of subjects in the diclofenac group who finished the study was 39 patients, comprising 11 men and 28 women.
ROI secretion by monocytes before treatment were 2.25 ± 0.23 in the curcuminoid group while 2.20 ± 0.21 in diclofenac group. Reactive oxygen intermediates play an important role in the process of inflammation and tissue damage. Exposure of ROI to normal cells will cause a variety of pathological changes leading to cell and tissue damage for example in pathogenesis of osteoarthritis (Ahmed et al., 2005; Shah et al., 2005) . Monocytes from patients with rheumatoid arthritis release increase amount of reactive oxygen intermediates. Reactive oxygen intermediates play an important role in the process of cartilage degradation in the pathogenesis of some rheumatic diseases through lipid peroxidation in chondrocytes (Arora et al., 2000) . In this study the ROI secretion by synovial fluid monocytes was not significantly different between the two groups (p = 0.16). 
Kertia.et al
The distribution of ROI secretion by monocytes before treatment spread follow a normal curve with p = 0.200 (Figure 2) . To analyze the differences of ROI secretion between both group the independent t -test was used, because subjects in curcuminoid group were not same to the subjects in diclofenac group.
ROI secretion by synovial fluid monocytes was significantly decreased in both groups with p <0.001 respectively (Table 2) . Oxidative stress stimulate the peroxidation of lipid membranes and able to cause a serious cells damage. Changes in biological condition of the cell membranes will increase tissue permeability and disrupt the normal function of these cells. Reactive oxygen intermediates is one of the oxidative markers could be detected in the laboratory (Tiku et al., 2000) In elimination process of the foreign antigens or when interacting with stimuli such as cytokines, the oxidative burst of monocytes showed an increased capacity to produce ROI in large quantities (Donne et al., 2006) . Reactive oxygen intermediates play a role in the process of inflammation and tissue damage in osteoarthritis (Shah et al., 2005) . In experimental animals curcumin suppress the production of Nitrite Oxyde (NO) and superoxide anions (O 2 -). There are differential roles of nitric oxide and oxygen radicals in chondrocytes affected by osteoarthritis and rheumatoid arthritis (Mazzetti et al., 2001) . Curcumin inhibits the in vitro secretion of ROI by gum fibroblasts and human submandibular gland carcinoma cells (Atsumi et al., 2005) . Curcumin Inhibits ROS Formation and Apoptosis in Methylglyoxal-Treated Human Hepatoma G2 Cells (Chan et al., 2005) . The results of this study indicate that there was no significant difference in decreasing of ROI secretion by synovial fluid monocytes during treatment between the two groups ( Table  3 ). The ability of both drugs did not differ The number needed to be treated analysis of the secretion of ROI by synovial fluid monocytes get that to obtain one subject with decreasing of ROI secretion with the target score of less than 1 in the group that received diclofenac sodium compared to curcuminoid from Curcuma domestica Val. rhyzome extract, the number of subjects needed to be treated are 9 patients (Table 4) .
Oraly treatment by curcuminoid from Curcuma domestica Val. rhyzome extract significantly inhibite the secretion of ROI by monocytes synovial fluid of osteoarthritic joint. The ability of curcuminoid from Curcuma domestica Val. rhyzome extract in inhibite the secretion of ROI by monocytes synovial fluid is not significantly different compared to diclofenac sodium.
